Introduction {#section1-1179546818759286}
============

Noncommunicable diseases (NCDs), such as cardiovascular diseases (CVDs), diabetes, cancers, and chronic respiratory diseases, are typically found in developed countries due to the predominantly sedentary lifestyle and cause 63% or more deaths in the world. By increasing the risk factors, CVD is one of the most prominent NCDs and it is the cause of one-third of deaths worldwide.^[@bibr1-1179546818759286]^ The increased cardiovascular risk in the world population could have several causes including dyslipidemia, diabetes mellitus, hypertension (HTN), higher body mass index (BMI), higher waist to hip ratio, or impaired physical fitness.^[@bibr2-1179546818759286]^ Among these, the plasma lipid profile is the major risk factor and predictor for CVD, acute myocardial infarction, and stroke.^[@bibr3-1179546818759286]^

Previous studies indicated that total cholesterol (TC) is a risk factor for carotid atherosclerosis and has been associated with high-serum triglyceride (TG) and low-serum high-density lipoprotein cholesterol (HDL-C) concentrations.^[@bibr4-1179546818759286]^ The importance of low-density lipoprotein (LDL) cholesterol in the development of atherosclerosis has long been recognized, and LDL-C remains the primary target of the therapy for the prevention of coronary heart disease (CHD). Nevertheless, increasing research attention over the past decade has been devoted to the heterogeneity of LDL-C particles and the atherogenicity of lipids and lipoproteins other than LDL-C.^[@bibr5-1179546818759286]^ On that basis, atherogenic dyslipidemia, defined as high LDL-C/HDL-C ratio and high TAG, is associated with high cardiovascular risk.^[@bibr6-1179546818759286]^ For better evaluation and to predict the risk of CVD, many clinical studies have attempted to introduce another marker of atherogenic dyslipidemia such as atherogenic index (AI) and coronary risk index (CRI).^[@bibr7-1179546818759286]^

It is known that a large number of cardiovascular risk factors are modifiable, and so far, efforts have been put in this direction but much more is needed. For this purpose, it is necessary to know how these different risk factors affect each other. Within this context and to clarify the role and contribution of the lipid atherogenic risk that could help predict CVD risk, the correlation between AI, as a major risk factor of CVD, and other important factors such as BMI, HTN, waist circumference, and lipid status were assessed.

Methods {#section2-1179546818759286}
=======

A total of 5207 subjects (2499 men and 2708 women), aged between 15 and 70 years, were asked to complete a checklist of study variables and patients' blood sample results including sex (male, female), age (\<30, 31-40, 41-50, \>50), waist circumference (obese \>90 cm for both sexes), fasting blood glucose (mg/dL), cholesterol (mg/dL), TG (mg/dL), HDL (mg/dL), and LDL (mg/dL) after obtaining informed consent. The protocol for the study was approved by the Research and Ethics Committee of Birjand University of Medical Sciences. The anthropometric measurements were determined by weighting scale and measuring tape. Based on the values of BMI, participants were classified as underweight (BMI \< 18.5 kg/m^2^), normal (BMI: 18.5-24.9 kg/m^2^), overweight (BMI: 25-29.9 kg/m^2^), and obese (BMI ≥ 30 kg/m^2^). After completing the checklist, fasting blood samples were collected and sent to the lab. Serum was separated and stored in a freezer at −20°C until testing.^[@bibr7-1179546818759286]^ Atherogenic index (AI = LDL-C/HDL-C) and CRI (CRI = TC/HDL-C) were calculated for all subjects. Plasma lipid abnormality was based on the expert panel of the National Cholesterol Education Program (NCEP) cutoff values.^[@bibr8-1179546818759286]^ This study was approved by the research ethics committee of the university (Ethics Code 1392-09-22) and adhered to the Declaration of Helsinki.

The test results and medical recommendations were given to the patients and after surveying the information and ensuring that they were correctly entered into the IBM SPSS software (version 22), descriptive information was presented using mean and standard error and then data were analyzed by independent sample *t* test, 1-way analysis of variance method and Pearson correlation. A *P* value of less than .05 was considered significant.

Results {#section3-1179546818759286}
=======

This study assessed the correlation between AI, as a major risk factor of CVD, and other important factors such as BMI, HTN, waist circumference, and lipid status. A total of 5207 subjects aged between 15 and 70 years were asked to complete a checklist of study variables and patients' blood sample results.

[Table 1](#table1-1179546818759286){ref-type="table"} shows the general characteristics of the population study. From a total of 5207 participants, 2708 (52%) were women, most of them (1636 participants, 31.4%) were more than 50 years old, 1656 (31.8%) were overweight, and 881 (16.9%) were obese. In addition, 366 participants (7.0%) were in the habit of taking tobacco. [Table 2](#table2-1179546818759286){ref-type="table"} shows the mean and standard error of BMI, lipid profile, and AIs among the age groups. Based on the results, there were no significant differences in BMI values between age groups. Although TC, LDL-C, TG, CRI, and AI increase by age (*P* \< .001), subjects less than 30 years had a higher mean of HDL-C (40.10) compared with subjects aged above 50 years (*P* \< .001).

###### 

General characteristics of the study.

![](10.1177_1179546818759286-table1)

  Variables             Frequency   \%
  --------------------- ----------- ------
  Sex                               
   Male                 2499        48
   Female               2708        52
   Total                5207        100
  Age groups, y                     
   \<30                 1398        26.8
   31--40               1172        22.5
   41--50               1001        19.2
   \>50                 1636        31.4
   Total                5207        100
  BMI groups, kg/m^2^               
   \<18.5               450         8.6
   18.5--24.9           1897        36.4
   25--29.9             1656        31.8
   \>30                 881         16.9
   Total                4884        93.8
  Tobacco intake                    
   Yes                  366         7.0
   No                   4776        91.7

Abbreviation: BMI, body mass index.

###### 

Comparison of BMI, lipid profile, and atherogenic indices among the age groups.

![](10.1177_1179546818759286-table2)

  Variables           Age groups, y                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  ------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  BMI                 24.14 (0.75)                                                                                                                                                                       27.37 (2.18)                                                                                                                                                                       33.55 (5.39)                                                                                                                                                                       28.69 (1.67)
  Total cholesterol   170.19 (0.89)^[b](#table-fn4-1179546818759286){ref-type="table-fn"},[c](#table-fn5-1179546818759286){ref-type="table-fn"},[d](#table-fn6-1179546818759286){ref-type="table-fn"}^   186.16 (1.01)^[a](#table-fn3-1179546818759286){ref-type="table-fn"},[c](#table-fn5-1179546818759286){ref-type="table-fn"},[d](#table-fn6-1179546818759286){ref-type="table-fn"}^   193.42 (1.09)^[a](#table-fn3-1179546818759286){ref-type="table-fn"},[b](#table-fn4-1179546818759286){ref-type="table-fn"},[d](#table-fn6-1179546818759286){ref-type="table-fn"}^   201.46 (0.97)^[a](#table-fn3-1179546818759286){ref-type="table-fn"},[b](#table-fn4-1179546818759286){ref-type="table-fn"},[c](#table-fn5-1179546818759286){ref-type="table-fn"}^
  LDL-C               108.89 (0.85)^[b](#table-fn4-1179546818759286){ref-type="table-fn"},[c](#table-fn5-1179546818759286){ref-type="table-fn"},[d](#table-fn6-1179546818759286){ref-type="table-fn"}^   120.17 (0.97)^[a](#table-fn3-1179546818759286){ref-type="table-fn"},[c](#table-fn5-1179546818759286){ref-type="table-fn"},[d](#table-fn6-1179546818759286){ref-type="table-fn"}^   124.37 (1.06)^[a](#table-fn3-1179546818759286){ref-type="table-fn"},[b](#table-fn4-1179546818759286){ref-type="table-fn"},[d](#table-fn6-1179546818759286){ref-type="table-fn"}^   131.27 (0.88)^[a](#table-fn3-1179546818759286){ref-type="table-fn"},[b](#table-fn4-1179546818759286){ref-type="table-fn"},[c](#table-fn5-1179546818759286){ref-type="table-fn"}^
  HDL-C               40.10 (0.23)^[d](#table-fn6-1179546818759286){ref-type="table-fn"}^                                                                                                                39.56 (0.24)                                                                                                                                                                       39.30 (0.26)                                                                                                                                                                       39.33 (0.19)^[a](#table-fn3-1179546818759286){ref-type="table-fn"}^
  Triglyceride        126.25 (1.85)^[b](#table-fn4-1179546818759286){ref-type="table-fn"},[c](#table-fn5-1179546818759286){ref-type="table-fn"},[d](#table-fn6-1179546818759286){ref-type="table-fn"}^   145.77 (2.29)^[a](#table-fn3-1179546818759286){ref-type="table-fn"},[c](#table-fn5-1179546818759286){ref-type="table-fn"},[d](#table-fn6-1179546818759286){ref-type="table-fn"}^   164.89 (2.83)^[a](#table-fn3-1179546818759286){ref-type="table-fn"},[b](#table-fn4-1179546818759286){ref-type="table-fn"}^                                                         170.53 (2.41)^[a](#table-fn3-1179546818759286){ref-type="table-fn"},[b](#table-fn4-1179546818759286){ref-type="table-fn"}^
  CRI                 4.38 (0.03)^[b](#table-fn4-1179546818759286){ref-type="table-fn"},[c](#table-fn5-1179546818759286){ref-type="table-fn"},[d](#table-fn6-1179546818759286){ref-type="table-fn"}^     4.86 (0.03)^[a](#table-fn3-1179546818759286){ref-type="table-fn"},[c](#table-fn5-1179546818759286){ref-type="table-fn"},[d](#table-fn6-1179546818759286){ref-type="table-fn"}^     5.08 (0.03)^[a](#table-fn3-1179546818759286){ref-type="table-fn"},[b](#table-fn4-1179546818759286){ref-type="table-fn"},[d](#table-fn6-1179546818759286){ref-type="table-fn"}^     5.26 (0.03)^[a](#table-fn3-1179546818759286){ref-type="table-fn"},[b](#table-fn4-1179546818759286){ref-type="table-fn"},[c](#table-fn5-1179546818759286){ref-type="table-fn"}^
  AI                  2.79 (0.02)^[b](#table-fn4-1179546818759286){ref-type="table-fn"},[c](#table-fn5-1179546818759286){ref-type="table-fn"},[d](#table-fn6-1179546818759286){ref-type="table-fn"}^     3.12 (0.03)^[a](#table-fn3-1179546818759286){ref-type="table-fn"},[c](#table-fn5-1179546818759286){ref-type="table-fn"},[d](#table-fn6-1179546818759286){ref-type="table-fn"}^     3.25 (0.03)^[a](#table-fn3-1179546818759286){ref-type="table-fn"},[b](#table-fn4-1179546818759286){ref-type="table-fn"},[d](#table-fn6-1179546818759286){ref-type="table-fn"}^     3.41 (0.02)^[a](#table-fn3-1179546818759286){ref-type="table-fn"},[b](#table-fn4-1179546818759286){ref-type="table-fn"},[c](#table-fn5-1179546818759286){ref-type="table-fn"}^

Abbreviations: AI, atherogenic index; BMI, body mass index; CRI, coronary risk index; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein.

Significant difference with first group.

Significant difference with second group.

Significant difference with third group.

Significant difference with last group.

[Table 3](#table3-1179546818759286){ref-type="table"} shows a comparison of lipid profile and AIs among the BMI categories. Based on the results, TC, CRI, and AI increased by age (*P* \< .001). Moreover, the mean LDL-C was significantly different in BMI categories and increased with age except in overweight and obese subjects. Also, the mean HDL-C in the underweight and normal groups was statistically different from the overweight and obese groups (*P* \< .001). The HDL-C mean was more in underweight and normal subjects than the 2 other groups. The same results were observed for TG. In addition, overweight and obese subjects had a significant difference in means and it also increased by age (*P* \< .001).

###### 

Comparison of lipid profile and atherogenic indices among the BMI groups.

![](10.1177_1179546818759286-table3)

  Variables           BMI groups, kg/m^2^                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  ------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Total cholesterol   175.07 (1.65)^[b](#table-fn9-1179546818759286){ref-type="table-fn"},[c](#table-fn10-1179546818759286){ref-type="table-fn"},[d](#table-fn11-1179546818759286){ref-type="table-fn"}^   182.33 (0.82)^[a](#table-fn8-1179546818759286){ref-type="table-fn"},[c](#table-fn10-1179546818759286){ref-type="table-fn"},[d](#table-fn11-1179546818759286){ref-type="table-fn"}^   193.21 (0.88)^[a](#table-fn8-1179546818759286){ref-type="table-fn"},[b](#table-fn9-1179546818759286){ref-type="table-fn"},[d](#table-fn11-1179546818759286){ref-type="table-fn"}^   197.39 (1.24)^[a](#table-fn8-1179546818759286){ref-type="table-fn"},[b](#table-fn9-1179546818759286){ref-type="table-fn"},[c](#table-fn10-1179546818759286){ref-type="table-fn"}^
  LDL-C               111.92 (1.46)^[b](#table-fn9-1179546818759286){ref-type="table-fn"},[c](#table-fn10-1179546818759286){ref-type="table-fn"},[d](#table-fn11-1179546818759286){ref-type="table-fn"}^   118.92 (0.76)^[a](#table-fn8-1179546818759286){ref-type="table-fn"},[c](#table-fn10-1179546818759286){ref-type="table-fn"},[d](#table-fn11-1179546818759286){ref-type="table-fn"}^   123.90 (0.81)^[a](#table-fn8-1179546818759286){ref-type="table-fn"},[b](#table-fn9-1179546818759286){ref-type="table-fn"}^                                                          127.09 (1.19)^[a](#table-fn8-1179546818759286){ref-type="table-fn"},[b](#table-fn9-1179546818759286){ref-type="table-fn"}^
  HDL-C               40.82 (0.38)^[c](#table-fn10-1179546818759286){ref-type="table-fn"},[d](#table-fn11-1179546818759286){ref-type="table-fn"}^                                                          40.38 (0.19)^[c](#table-fn10-1179546818759286){ref-type="table-fn"},[d](#table-fn11-1179546818759286){ref-type="table-fn"}^                                                          38.95 (0.19)^[a](#table-fn8-1179546818759286){ref-type="table-fn"},[b](#table-fn9-1179546818759286){ref-type="table-fn"}^                                                           38.42 (0.26)^[a](#table-fn8-1179546818759286){ref-type="table-fn"},[b](#table-fn9-1179546818759286){ref-type="table-fn"}^
  Triglyceride        123.94 (3.36)^[c](#table-fn10-1179546818759286){ref-type="table-fn"},[d](#table-fn11-1179546818759286){ref-type="table-fn"}^                                                         133.06 (1.62)^[c](#table-fn10-1179546818759286){ref-type="table-fn"},[d](#table-fn11-1179546818759286){ref-type="table-fn"}^                                                         166.80 (2.23)^[a](#table-fn8-1179546818759286){ref-type="table-fn"},[b](#table-fn9-1179546818759286){ref-type="table-fn"},[d](#table-fn11-1179546818759286){ref-type="table-fn"}^   178.62 (3.00)^[a](#table-fn8-1179546818759286){ref-type="table-fn"},[b](#table-fn9-1179546818759286){ref-type="table-fn"},[c](#table-fn10-1179546818759286){ref-type="table-fn"}^
  CRI                 4.40 (0.05)^[b](#table-fn9-1179546818759286){ref-type="table-fn"},[c](#table-fn10-1179546818759286){ref-type="table-fn"},[d](#table-fn11-1179546818759286){ref-type="table-fn"}^     4.65 (0.02)^[a](#table-fn8-1179546818759286){ref-type="table-fn"},[c](#table-fn10-1179546818759286){ref-type="table-fn"},[d](#table-fn11-1179546818759286){ref-type="table-fn"}^     5.11 (0.03)^[a](#table-fn8-1179546818759286){ref-type="table-fn"},[b](#table-fn9-1179546818759286){ref-type="table-fn"},[d](#table-fn11-1179546818759286){ref-type="table-fn"}^     5.30 (0.04)^[a](#table-fn8-1179546818759286){ref-type="table-fn"},[b](#table-fn9-1179546818759286){ref-type="table-fn"},[c](#table-fn10-1179546818759286){ref-type="table-fn"}^
  AI                  2.81 (0.04)^[b](#table-fn9-1179546818759286){ref-type="table-fn"},[c](#table-fn10-1179546818759286){ref-type="table-fn"},[d](#table-fn11-1179546818759286){ref-type="table-fn"}^     3.03 (0.02)^[a](#table-fn8-1179546818759286){ref-type="table-fn"},[c](#table-fn10-1179546818759286){ref-type="table-fn"},[d](#table-fn11-1179546818759286){ref-type="table-fn"}^     3.26 (0.02)^[a](#table-fn8-1179546818759286){ref-type="table-fn"},[b](#table-fn9-1179546818759286){ref-type="table-fn"},[d](#table-fn11-1179546818759286){ref-type="table-fn"}^     3.39 (0.03)^[a](#table-fn8-1179546818759286){ref-type="table-fn"},[b](#table-fn9-1179546818759286){ref-type="table-fn"},[c](#table-fn10-1179546818759286){ref-type="table-fn"}^

Abbreviations: AI, atherogenic index; BMI, body mass index; CRI, coronary risk index; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein.

Significant difference with first group.

Significant difference with second group.

Significant difference with third group.

Significant difference with last group.

The results of the comparison of lipid profiles by sex ([Figure 1](#fig1-1179546818759286){ref-type="fig"}) showed that the mean values of TC (*P* = .012) and HDL-C (*P* \< .001) were more in women than men (189.19, 41.17 in women and 186.91, 37.88 in men). Moreover, the results indicated that the mean values of TG (*P* \< .001), CRI (*P* \< .001), and AI (*P* \< .001) were more in men than women (160.72, 5.08, and 3.26 in men; 143.93, 4.74, and 3.05 in women). In addition, LDL and BMI levels showed no significant difference by sex.

![Comparison of BMI, lipid profile, and atherogenic indices related to sex. AI indicates atherogenic index; BMI, body mass index; CRI, coronary risk index; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TC, total cholesterol; TG, triglyceride.](10.1177_1179546818759286-fig1){#fig1-1179546818759286}

[Figure 2](#fig2-1179546818759286){ref-type="fig"} shows the correlation between lipid profile and AIs in a correlation matrix figure (vertical axis and horizontal axis are variables mentioned in the diameter). The CRI has a positive and significant relationship with TC, LDL-C, systolic blood pressure (SBP), diastolic blood pressure (DBP), and TG. In other words, CRI increases with increasing TC, LDL-C, or TAG values (*P* \< .001). In addition, the relationship between CRI and HDL-C was significantly negative. Thus, CRI increases with a decrease in HDL-C and vice versa (*P* \< .001). Another index, AI, has a direct relationship with TC, LDL-C, SBP, DBP, and TAG; it means that AI increases with increasing TC, LDL-C, or TAG values (*P* \< .001). The relationship between AI and HDL-C was significantly negative and AI increases with decrease in HDL-C and vice versa (*P* \< .001).

![Correlation between lipid profile and atherogenic indices. AI indicates atherogenic index; CRI, coronary risk index; DBP, diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride.\
\*\*\*Statistically significant at α = .001](10.1177_1179546818759286-fig2){#fig2-1179546818759286}

Discussion {#section4-1179546818759286}
==========

The alteration in the serum levels of the lipid profile; increase in TC, TG, and LDL-C; and decrease in HDL-C are major factors for the development of CVDs.^[@bibr9-1179546818759286],[@bibr10-1179546818759286]^ Atherogenic index (LDL-C/HDL-C) and CRI (TC/HDL-C) as a strong marker to predict the risk of atherosclerosis and CHD and noninvasive parameters reveal the presence of LDL or TAG in the serum of related patients. Recently, it has been demonstrated that investigators provide considerable predictors.^[@bibr10-1179546818759286][@bibr11-1179546818759286][@bibr12-1179546818759286]--[@bibr13-1179546818759286]^ Furthermore, in conditions where other atherogenic risk parameters seem normal, AI and CRI may be the alternative diagnostic choices. In this study, it appears that there is a correlation between aging, BMI, sex, and CVDs; therefore, an estimate was made of the cross-sectional association between AI and other risk factors of CVD among 5207 candidate individuals in Birjand, east of Iran.

The results showed that 31.4% of candidate individuals are more than 50 years old and by aging the TC, LDL-C, TAG, CRI, and AI increased and were statistically significant.

The BMI reached the highest level in individuals aged between 41 and 50 years. Total cholesterol, LDL-C, TAG, CRI, and AI increased with increasing BMI. By comparing the lipid profile with AI in related subjects, TC, CRI, and AI increased (*P* \< .001) among the candidates. Furthermore, HDL-C and TAG were statistically significant in this population; although TAG was seen more in obese and overweight individuals and vice versa for HDL-C (*P* \< .001).

Overall, the women had more BMI than the men. By comparing the lipid profile with sex, the mean values of TC and HDL-C were higher in women, whereas the mean values of TAG, CRI, and AI were more in men. These findings were statistically significant.

According to our data, CRI and AI had affirmative correlation with TC, LDL-C, TAG, SBP, and DBP. By increasing these factors, these 2 indices were augmented.

According to previous studies, all these parameters are important risk factors for CVD.

A concordance was observed between increased AI and the significant increase in the value of, LDL-C, TC, and TAG, as well as SBP and DBP. This result is similar to the results of Karen et al.^[@bibr14-1179546818759286],[@bibr15-1179546818759286]^

In accordance with our study, in a sample of Turkish population, the high AI of the plasma reflected obesity and hyperinsulinemia in men. It independently predicts CHD and type 2 diabetes in men and in women, high blood pressure, and metabolic syndrome. Therefore, high AI of plasma (AIP) is a powerful risk factor for coronary artery disease in both Turkish men and women.^[@bibr16-1179546818759286]^

In line with this study, Pallavi et al assessed the AI and lipid profile in obese and nonobese women. They showed that in middle-aged women, the significant increase in AI was linked with increasing BMI (*P* \< .05).^[@bibr17-1179546818759286]^

In agreement with our data, Jobert et al reported that AIP may not be an independent factor affecting the risk of CVD among Cameroonian postmenopausal women. Results from this study showed that AIP and the risk of CVD were significantly correlated with each other; however, this correlation was weak (*r* = .369).^[@bibr18-1179546818759286]^

Moreover, Nwagha and Igwe^[@bibr19-1179546818759286]^ showed the massive contributions of TAG to cardiovascular risk. In fact, high levels of TAG have been linked with an increased incidence of CHD.^[@bibr20-1179546818759286]^ Furthermore, the results indicated that AIP has a statistically marked difference (*P* = .001) between patients and healthy people. It revealed their positive association with severity of CHD.

Furthermore, Hadaegh et al^[@bibr9-1179546818759286]^ reported that among Iranian men, the TAG/HDL-C ratio has disclosed a considerable adjusted (multivariable) risk ratio of 1.75 which was similar to the observation of Onat et al.^[@bibr16-1179546818759286]^ They demonstrated that among women with myocardial ischemia, the TAG/HDL-C ratio was monitored to be an independent predictor of cardiovascular incidents and of mortality in multi-adjusted models.^[@bibr21-1179546818759286]^

Niroumand et al^[@bibr22-1179546818759286]^ stated that male participants were dominant in the increased-risk AIP category; hence, they were at a higher risk of developing CHD. This finding agrees with the study of Khazaál.^[@bibr23-1179546818759286]^

It has been reported that AIP plays a predictive role for atherosclerosis^[@bibr24-1179546818759286],[@bibr25-1179546818759286]^ and can be used as an available index of the highest sensitivity for assessing cardiovascular risk factors and for predicting acute coronary events.^[@bibr26-1179546818759286]^ Moreover, in situations where all atherogenic parameters are normal, AIP may be the alternative screening tool.^[@bibr23-1179546818759286]^

Conclusions {#section5-1179546818759286}
===========

The result of this study can be applied to return the bleak prognosis of CVD and also can help policymakers to implement a population strategy in association with a high-risk group strategy for CVD prevention and reduce the burden of CVD in future decades.

In this study, risk factors such as alcohol consumption, physical activity, and diet were not considered, in the event that this information enables us to have a more accurate evaluation. Considering common and uncommon risk factors together promoted the prognosis and prevention of metabolic disorders.
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